Starpharma Holdings Limited
Starpharma Holdings Limited (SPHRY) Stock Overview
Explore Starpharma Holdings Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
140.7M
P/E Ratio
-205.80
EPS (TTM)
$-0.06
ROE
-0.05%
SPHRY Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Starpharma Holdings Limited (SPHRY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 62.18, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $4.27.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -205.80 and a market capitalization of 140.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.